For the millions of adults navigating early Alzheimer's disease or mild cognitive impairment, the question of whether lifestyle changes can meaningfully slow brain deterioration carries enormous weight. New longitudinal neuroimaging data suggest that structured exercise may do exactly that — at least temporarily — by preserving the very structures most vulnerable to Alzheimer's pathology and reconfiguring how those structures communicate during rest.
The MOVE study enrolled 46 individuals on the Alzheimer's continuum, randomizing them to either six months of multimodal exercise or a psychoeducation control, then tracking both groups for an additional 12 months. Using high-resolution structural MRI and resting-state fMRI, investigators measured volumes of discrete hippocampal and amygdala subfields — granular anatomical targets rarely assessed in exercise trials — alongside functional connectivity between these regions. After the six-month active intervention, exercisers demonstrated measurably reduced subfield atrophy and increased hippocampus-amygdala resting-state connectivity compared to controls. Crucially, these structural and connectivity gains correlated meaningfully with sleep quality metrics, physical activity levels, and cognitive performance scores. However, one year after the intervention ended, both groups showed resumed cognitive decline and hippocampal atrophy, suggesting the benefits did not outlast the behavior.
This finding sits at an important intersection of the sleep-exercise-dementia triad. Disrupted sleep is now well-established as both a risk factor for and consequence of Alzheimer's pathology, with amyloid clearance partially dependent on adequate slow-wave sleep. What this trial adds is a mechanistic bridge: exercise may preserve the hippocampal-amygdala circuitry that regulates sleep architecture, creating a feedback loop that benefits cognition. The critical limitation here is sample size — 46 participants is too small for definitive causal conclusions, and the study was not powered to detect subgroup effects. The fadeout of benefit after cessation is a sobering but important signal, reinforcing that exercise functions more like a medication requiring ongoing dosing than a one-time intervention. This is confirmatory of the exercise-neuroprotection literature but adds rare subfield-level precision.
